Researchers at the University of Arkansas have developed a new nano drug candidate that kills triple negative breast cancer cells. WHAT IS TRIPLE NEGATIVE BREAST CANCER? Triple negative breast cancer is aggressive and lacks estrogen receptors, progesterone receptors and human epidermal growth factor receptor 2, which means it cannot be treated with receptor-targeted therapy. It is…